| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff15901344342bef4ca57676770131e4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1051 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06 |
| filingDate |
2005-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3df031842e5e831d1b0360b27e8d5f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_145f458e85918330a1899bb42be8845e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6872f545c9e151ed20fc8c414be86ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f4ecbf936614c32a3d30309b7873af4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f264810d694d42f87c98f9205ef88458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42cc56d20cdf4b98c9f4aa846cf333c2 |
| publicationDate |
2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008293141-A1 |
| titleOfInvention |
Cell for Producing Retrovirus Vector |
| abstract |
The N-acetylglucosaminyltransferase III activity is enhanced in a cell carrying retrovirus-origin gag-pol gene and env gene. By constructing a retrovirus vector with the use of the above cell, a retrovirus vector having a modified sugar chain structure can be obtained. The retrovirus vector constructed by this method shows a high infection efficiency particularly in the presence of a functional substance. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010148203-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11060112-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10316333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9422576-B2 |
| priorityDate |
2004-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |